Correlation Between Medicenna Therapeutics and HLS Therapeutics

Can any of the company-specific risk be diversified away by investing in both Medicenna Therapeutics and HLS Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicenna Therapeutics and HLS Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medicenna Therapeutics Corp and HLS Therapeutics, you can compare the effects of market volatilities on Medicenna Therapeutics and HLS Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicenna Therapeutics with a short position of HLS Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicenna Therapeutics and HLS Therapeutics.

Diversification Opportunities for Medicenna Therapeutics and HLS Therapeutics

-0.62

Correlation Coefficient

Medicenna Therapeutics  HLS Therapeutics

Excellent diversification

The 3 months correlation between Medicenna and HLS is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Medicenna Therapeutics Corp and HLS Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLS Therapeutics and Medicenna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicenna Therapeutics Corp are associated (or correlated) with HLS Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLS Therapeutics has no effect on the direction of Medicenna Therapeutics i.e., Medicenna Therapeutics and HLS Therapeutics go up and down completely randomly.

Pair Corralation between Medicenna Therapeutics and HLS Therapeutics

Assuming the 90 days trading horizon Medicenna Therapeutics Corp is expected to under-perform the HLS Therapeutics. In addition to that, Medicenna Therapeutics is 1.61 times more volatile than HLS Therapeutics. It trades about -0.22 of its total potential returns per unit of risk. HLS Therapeutics is currently generating about 0.15 per unit of volatility. If you would invest  390.00  in HLS Therapeutics on December 30, 2024 and sell it today you would earn a total of  76.00  from holding HLS Therapeutics or generate 19.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Medicenna Therapeutics Corp  vs.  HLS Therapeutics

Medicenna Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Medicenna Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

HLS Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, HLS Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Medicenna Therapeutics and HLS Therapeutics

The main advantage of trading using opposite Medicenna Therapeutics and HLS Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicenna Therapeutics position performs unexpectedly, HLS Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLS Therapeutics will offset losses from the drop in HLS Therapeutics' long position.

The idea behind Medicenna Therapeutics Corp and HLS Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.